Burdock and Blood Pressure in African-American Women

July 29, 2015 updated by: Proactive Health Labs

Burdock and Blood Pressure in African-American Women: A Randomized Controlled Trial

This is a study of women aged 18-65, to determine the physiological effects of consuming burdock root in supplement form. Burdock has long been used by herbalists for its diuretic and blood sugar lowering properties.

Study Overview

Status

Unknown

Conditions

Detailed Description

This study will allow us to determine the effect of burdock consumption on basic laboratory tests such as the complete metabolic panel (CMP) as well as the effect on blood pressure over time. Participants will self-monitor their blood pressures and undergo lab testing. They will also complete symptom inventories to determine subjective factors that change with burdock consumption, such as menstrual water retention. Subjects will undergo electronic body composition testing before and after the intervention.

Study Type

Interventional

Enrollment (Anticipated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Must be able to swallow tablets
  • African-American race
  • Able to travel to our clinic in Santa Monica

Exclusion Criteria:

  • Severely low blood pressure
  • Hypoglycemia
  • Baseline creatinine over 1.2

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Placebo
Patients will consume a placebo pill containing methylcellulose.
Methylcellulose (inert) tablet taken as placebo
Active Comparator: Active
Patients will consume 850 mg of burdock twice per day.
Subjects will consume burdock daily and will undergo laboratory tests to determine the effect of burdock, if any, on organ function.
Other Names:
  • Arctium lappa

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Blood pressure
Time Frame: 6 weeks
6 weeks

Secondary Outcome Measures

Outcome Measure
Time Frame
Body fat percentage
Time Frame: 6 Weeks
6 Weeks
Extracellular/Total Body Water Ratio
Time Frame: 6 Weeks
6 Weeks
Hemoglobin A1c
Time Frame: 6 weeks
6 weeks
Blood urea nitrogen
Time Frame: 6 weeks
6 weeks
Creatinine
Time Frame: 6 weeks
6 weeks
Fasting Blood Glucose
Time Frame: 6 weeks
6 weeks
Liver function tests
Time Frame: 6 weeks
6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Dr. De, Proactive Health Labs

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2015

Primary Completion (Anticipated)

November 1, 2015

Study Completion (Anticipated)

February 1, 2016

Study Registration Dates

First Submitted

July 15, 2015

First Submitted That Met QC Criteria

July 29, 2015

First Posted (Estimate)

July 30, 2015

Study Record Updates

Last Update Posted (Estimate)

July 30, 2015

Last Update Submitted That Met QC Criteria

July 29, 2015

Last Verified

July 1, 2015

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 00000001

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypertension

Clinical Trials on Placebo

3
Subscribe